rofecoxib has been researched along with Alveolar Bone Atrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sculean, A | 1 |
| Berakdar, M | 1 |
| Donos, N | 1 |
| Auschill, TM | 1 |
| Arweiler, NB | 1 |
1 trial available for rofecoxib and Alveolar Bone Atrophy
| Article | Year |
|---|---|
The effect of postsurgical administration of a selective cyclo-oxygenase-2 inhibitor on the healing of intrabony defects following treatment with enamel matrix proteins.
Topics: Alveolar Bone Loss; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhi | 2003 |